Skip to content

Prescribing Drugs: Dissemination, Efficiency and Quality (WirtMed-Study). Subproject C: Effects of the Bavarian Drug Agreement on the micro level

Prescribing Drugs: Dissemination, Efficiency and Quality (WirtMed-Study). Subproject C: Effects of the Bavarian Drug Agreement on the micro level

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00019820
Enrollment
50
Registered
2019-12-02
Start date
2019-10-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prescription behaviour for diseases with long-term therapy

Interventions

Group 1: Registered physicians in Bavaria are interviewed on their prescription situation (perception of the Bavarian Drug Agreement) as part of an interview or a focus group. The recruitment of the r

Sponsors

Abteilung für Allgemeinmedizin, Präventive und Rehabilitative Medizin Philipps-Universität Marburg
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Physicians in Bavaria, belonging to a group of specialists in the outpatient sector, practice with extensive drug prescriptions

Exclusion criteria

Exclusion criteria: no registered physician in private practice in Bavaria, practice with small number of drug prescriptions

Design outcomes

Primary

MeasureTime frame
The physician's perception of the Bavarian Drug Agreement and the individual reactions to it will be investigated.

Secondary

MeasureTime frame
Further development of strategies and control methods related to drug prescriptions in the outpatient sector.

Countries

Germany

Contacts

Public ContactNikoletta Lippert

Allgemeinmedizinisches Insitut, Universitätsklinikum Erlangen

nikoletta.lippert@uk-erlangen.de09131-8545774

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026